We bring together global expertise to expose and address the threat of substandard and falsified medicines, safeguarding treatment efficacy and public health.

Medicine regulators assessing portable devices that detect substandard/falsified medication face a complex landscape: information about dozens of available devices is scattered, and no single device can detect all poor-quality medicines. DAFODIL brings together available scientific evidence in a single interactive digital platform, enabling comparison across devices, and helping regulators identify the best option for them.